EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis

Simona Musella, Danilo D'Avino iD, Lukas Klaus Peltner, Veronica Di Sarno, Ida Cerqua, Fabrizio Merciai, Vincenzo Vestuto, Tania Ciaglia, Gerardina Smaldone, Francesca Di Matteo, Simone Di Micco iD, Valeria Napolitano und 12 weitere

Journal of Medicinal Chemistry · 13.07.2023 · 66 (13) · 9201-9222

DOI: 10.1021/acs.jmedchem.3c00831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 19.06.2023. Verfasst von Simona Musella und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Via G. Paolo II 132, 84084 Fisciano, Salerno, Italy. Hauptthemen laut MEDLINE: Pancreatitis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, Associazione Italiana per la Ricerca sul Cancro, Università degli Studi di Napoli Federico II.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute pancreatitis (AP) is a potentially life-threatening illness characterized by an exacerbated inflammatory response with limited options for pharmacological treatment. Here, we describe the rational development of a library of soluble epoxide hydrolase (sEH) inhibitors for the treatment of AP. Synthesized compounds were screened in vitro for their sEH inhibitory potency and selectivity, and the results were rationalized by means of molecular modeling studies. The most potent compounds were studied in vitro for their pharmacokinetic profile, where compound 28 emerged as a promising lead. In fact, compound 28 demonstrated a remarkable in vivo efficacy in reducing the inflammatory damage in cerulein-induced AP in mice. Targeted metabololipidomic analysis further substantiated sEH inhibition as a molecular mechanism of the compound underlying anti-AP activity in vivo. Finally, pharmacokinetic assessment demonstrated a suitable profile of 28 in vivo. Collectively, compound 28 displays strong effectiveness as sEH inhibitor with potential for pharmacological AP treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatitisMiceAnimalsEpoxide HydrolasesAcute DiseaseEnzyme Inhibitors

Substanzen

Epoxide HydrolasesEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacy, University of Salerno, Via G. Paolo II 132, 84084 Fisciano, Salerno, Italy.
  • Department of Pharmacy, University Federico II of Naples, Via D. Montesano 49, 80131 Naples, Italy.
  • Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University, Philosophenweg 14, D-07743 Jena, Germany.
  • European Biomedical Research Institute (EBRIS), Via S. De Renzi 50, 84125 Salerno, Italy.
  • PhD Program in Drug Discovery and Development, University of Salerno, 84084 Fisciano, SA, Italy.

ORCID-Profile: Danilo D'Avino, Simone Di Micco, Giuseppe Bifulco, Giacomo Pepe, Isabel M Gomez-Monterrey, Pietro Campiglia, Carmine Ostacolo, Oliver Werz, Alessia Bertamino

Förderung

  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • Associazione Italiana per la Ricerca sul Cancro
  • Università degli Studi di Napoli Federico II

Zitieren

APA

Musella, S., D'Avino, D., Peltner, L. K., Di Sarno, V., Cerqua, I., Merciai, F., Vestuto, V., Ciaglia, T., Smaldone, G., Di Matteo, F., Di Micco, S., Napolitano, V., Bifulco, G., Pepe, G., Sommella, E. M., Basilicata, M. G., Aquino, G., Gomez-Monterrey, I. M., Campiglia, P., …, & Bertamino, A. (2023). Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis. Journal of Medicinal Chemistry, 66(13), 9201-9222. https://doi.org/10.1021/acs.jmedchem.3c00831

Vancouver

Musella S, D'Avino D, Peltner LK, Di Sarno V, Cerqua I, Merciai F, et al. Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis. Journal of Medicinal Chemistry. 2023;66(13):9201-9222. doi:10.1021/acs.jmedchem.3c00831

BibTeX
@article{Musella2023,
  author = {Musella, Simona and D'Avino, Danilo and Peltner, Lukas Klaus and Di Sarno, Veronica and Cerqua, Ida and Merciai, Fabrizio and Vestuto, Vincenzo and Ciaglia, Tania and Smaldone, Gerardina and Di Matteo, Francesca and Di Micco, Simone and Napolitano, Valeria and Bifulco, Giuseppe and Pepe, Giacomo and Sommella, Eduardo Maria and Basilicata, Manuela Giovanna and Aquino, Giovanna and Gomez-Monterrey, Isabel M and Campiglia, Pietro and Ostacolo, Carmine and Roviezzo, Fiorentina and Werz, Oliver and Rossi, Antonietta and Bertamino, Alessia},
  title = {Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {13},
  pages = {9201--9222},
  doi = {10.1021/acs.jmedchem.3c00831}
}
Kostenlos starten →